{"id":31765,"date":"2025-01-16T10:12:14","date_gmt":"2025-01-16T07:12:14","guid":{"rendered":"https:\/\/massivebio.com\/?p=31765"},"modified":"2025-05-26T13:02:52","modified_gmt":"2025-05-26T10:02:52","slug":"massive-bio-recognized-by-white-house-cancer-moonshot","status":"publish","type":"post","link":"https:\/\/massivebio.com\/massive-bio-recognized-by-white-house-cancer-moonshot\/","title":{"rendered":"Massive Bio Recognized by White House Cancer Moonshot, Launches $15 Million Initiative"},"content":{"rendered":"<section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Massive Bio Recognized by White House Cancer Moonshot for First-of-Their-Kind Pre-Screening Hubs and AI-Powered Trial Matching, Launches $15 Million Initiative at JPM 2025<\/strong><\/p>\n<p><strong>NEW YORK, January 15, 2025<\/strong> \u2013 Massive Bio today proudly announces its inclusion in the White House Office of Science &amp; Technology Policy\u2019s upcoming <strong>Cancer Moonshot Fact Sheet<\/strong>, underscoring the company\u2019s groundbreaking efforts to <strong>transform clinical trial access<\/strong> and <strong>accelerate just-in-time, decentralized trials<\/strong> for cancer patients worldwide. Aligned with its debut at the <strong>2025 JPMorgan Healthcare Conference (JPM 2025)<\/strong>, Massive Bio\u2019s <strong>$15 million<\/strong> initial investment will fuel its <strong>advanced AI-driven clinical trial matching platform<\/strong>, <strong>first-of-their-kind pre-screening hubs<\/strong>, and <strong>patient-centric \u2018hub and spoke\u2019 end-to-end activation<\/strong> model\u2014enabling more than 50,000 unique cancer patients annually and scaling to <strong>250,000 patients globally by 2027<\/strong>.<\/p>\n<h2 style=\"font-size: 24px;\"><strong>Proven Model for Just-in-Time and Decentralized Trials<\/strong><\/h2>\n<p>Massive Bio\u2019s proven model unifies a <strong>patient-centric \u2018hub and spoke\u2019 approach<\/strong> with advanced data analytics, ensuring <strong>rapid trial activation<\/strong> in both traditional and decentralized settings. By <strong>orchestrating remote patient screening, consent, and enrollment<\/strong>, the platform makes it possible for patients\u2014regardless of location\u2014to participate in cutting-edge clinical research, dramatically shortening timelines and streamlining resource use.<\/p>\n<h2 style=\"font-size: 24px;\"><strong>Groundbreaking Pre-Screening Hubs &amp; Real-Time Data Analytics<\/strong><\/h2>\n<ul>\n<li><strong>Pre-Screening Hubs:<\/strong> Utilizing <strong>comprehensive genomic profiling<\/strong> and <strong>real-world data<\/strong>, these hubs proactively identify eligible patients, reducing time-to-enrollment and boosting trial participation rates.<\/li>\n<li><strong>Real-Time Data Analytics:<\/strong> An <strong>AI-powered, 24\/7 monitoring system<\/strong> flags new trial opportunities or evolving patient eligibility, ensuring prompt and <strong>personalized<\/strong> guidance.<\/li>\n<\/ul>\n<p><strong>\u201cWe are thrilled to partner with the White House Cancer Moonshot, bridging critical gaps in care and advancing just-in-time and decentralized clinical trials. This is a wonderful recognition to the relentless work of all our team\u201d<\/strong> said <a style=\"text-decoration: underline; color: #0772ce;\" href=\"https:\/\/www.linkedin.com\/in\/selinkurnaz\/\" target=\"_blank\" rel=\"noopener\"><strong>Dr. Selin Kurnaz<\/strong><\/a>, CEO and Co-Founder of Massive Bio. <a style=\"text-decoration: underline; color: #0772ce;\" href=\"https:\/\/www.linkedin.com\/in\/cagatayculcuoglu\/\" target=\"_blank\" rel=\"noopener\"><strong>Cagatay Culcuoglu<\/strong><\/a>, COO\/CTO and Co-Founder added <strong>\u201cOur AI platform seamlessly integrates real-world evidence with advanced genomic insights, while our best-in-class patient-centric \u2018hub and spoke\u2019 strategy ensures every patient\u2014especially those in underserved and underrepresented communities\u2014benefits from equitable and efficient trial access.\u201d<\/strong><\/p>\n<p><strong>\u201cBy leveraging a truly collaborative, multi-stakeholder approach\u2014from healthcare providers and pharmaceutical sponsors to patient advocacy organizations\u2014we are redefining how clinical research is conducted,\u201d<\/strong> added <a style=\"text-decoration: underline; color: #0772ce;\" href=\"https:\/\/www.linkedin.com\/in\/arturoloaizabonillla\/\" target=\"_blank\" rel=\"noopener\"><strong>Dr. Arturo Loaiza-Bonilla<\/strong><\/a>, Chief Medical Officer and Co-Founder of Massive Bio. <strong>\u201cOur pre-screening hubs and real-time analytics provide the foundation for quicker activation, remote participation, and a frictionless experience for both patients and providers\u2014ultimately accelerating progress against cancer for communities worldwide.\u201d<\/strong><\/p>\n<h2 style=\"font-size: 24px;\"><strong>Collaboration for Equitable Access<\/strong><\/h2>\n<p>Designed with <strong>underserved and underrepresented populations<\/strong> in mind, Massive Bio\u2019s multi-stakeholder ecosystem <strong>streamlines data integration and resource-sharing<\/strong>, enabling a seamless patient journey and truly <strong>equitable clinical research<\/strong>.<\/p>\n<h2 style=\"font-size: 24px;\"><strong>Launch at JPM 2025 and Future Outlook<\/strong><\/h2>\n<p>The unveiling at <strong>JPM 2025<\/strong> will highlight Massive Bio\u2019s <strong>AI-driven, patient-centric approach<\/strong> and the <strong>scalable impact<\/strong> of its pre-screening hubs\u2014aimed at closing long-standing disparities in trial enrollment and bringing <strong>just-in-time, decentralized study opportunities<\/strong> to patients wherever they live. By <strong>2027<\/strong>, this platform will serve <strong>250,000 patients annually<\/strong>, propelling the global fight against cancer and delivering tangible hope to those who need it most.<\/p>\n<h2 style=\"font-size: 24px;\"><strong>About Massive Bio:<\/strong><\/h2>\n<p>Massive Bio\u2019s vision is to transform the entire pharmaceutical value chain with disruptive solutions that enhance the ecosystem from drug development to commercialization. As a unique AI-enabled real-world data company, Massive Bio addresses all friction points in the end-to-end patient journey, facilitating patient access to advanced treatment options and optimizing drug clinical trials and commercialization for pharmaceutical companies. Committed to breaking down barriers and enhancing equitable access to clinical trials, Massive Bio fosters value-based oncology decisions and facilitates data-driven cancer treatment. Founded in 2015 by a team of clinical, technology, and M&amp;A executives, Massive Bio has served over four dozen pharmaceutical companies, contract research organizations, and hospital networks. It is a founding member of the CancerX public-private partnership and participates in the Cancer Moonshot White House initiative. Massive Bio has earned recognition from the National Cancer Institute through an SBIR contract. Today, Massive Bio has a global presence with over 100 employees across 17 countries. For further details, please visit our website\u00a0<a style=\"text-decoration: underline; color: #0772ce;\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.massivebio.com%2F&amp;esheet=54122226&amp;newsitemid=20240916310756&amp;lan=en-US&amp;anchor=www.massivebio.com&amp;index=3&amp;md5=2fe283a69e56960ea6bbcdca67698d95\" target=\"_blank\" rel=\"noopener\">www.massivebio.com<\/a>\u00a0and connect with us on our social media channels.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"Massive Bio Recognized by White House Cancer Moonshot for First-of-Their-Kind Pre-Screening Hubs and AI-Powered Trial Matching, Launches $15 Million Initiative at JPM 2025 NEW YORK, January 15, 2025 \u2013 Massive Bio today proudly announces its inclusion in the White House Office of Science &amp; Technology Policy\u2019s upcoming Cancer Moonshot Fact Sheet, underscoring the company\u2019s groundbreaking...","protected":false},"author":11,"featured_media":31766,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55],"tags":[],"class_list":["post-31765","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Massive Bio today proudly announces its inclusion in the White House Office of Science &amp; Technology Policy\u2019s upcoming Cancer Moonshot Fact Sheet.<\/title>\n<meta name=\"description\" content=\"Massive Bio Recognized by White House Cancer Moonshot for First-of-Their-Kind Pre-Screening Hubs and AI-Powered Trial Matching, Launches $15 Million Initiative at JPM 2025.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/massivebio.com\/massive-bio-recognized-by-white-house-cancer-moonshot\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Massive Bio Recognized by White House Cancer Moonshot, Launches $15 Million Initiative %\" \/>\n<meta property=\"og:description\" content=\"Massive Bio Recognized by White House Cancer Moonshot for First-of-Their-Kind Pre-Screening Hubs and AI-Powered Trial Matching, Launches $15 Million Initiative at JPM 2025.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/massivebio.com\/massive-bio-recognized-by-white-house-cancer-moonshot\/\" \/>\n<meta property=\"og:site_name\" content=\"Massive Bio\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-16T07:12:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-26T10:02:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/WhiteHousePR.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"767\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Sinan Gul\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:site\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sinan Gul\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Massive Bio today proudly announces its inclusion in the White House Office of Science & Technology Policy\u2019s upcoming Cancer Moonshot Fact Sheet.","description":"Massive Bio Recognized by White House Cancer Moonshot for First-of-Their-Kind Pre-Screening Hubs and AI-Powered Trial Matching, Launches $15 Million Initiative at JPM 2025.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/massivebio.com\/massive-bio-recognized-by-white-house-cancer-moonshot\/","og_locale":"en_US","og_type":"article","og_title":"Massive Bio Recognized by White House Cancer Moonshot, Launches $15 Million Initiative %","og_description":"Massive Bio Recognized by White House Cancer Moonshot for First-of-Their-Kind Pre-Screening Hubs and AI-Powered Trial Matching, Launches $15 Million Initiative at JPM 2025.","og_url":"https:\/\/massivebio.com\/massive-bio-recognized-by-white-house-cancer-moonshot\/","og_site_name":"Massive Bio","article_publisher":"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","article_published_time":"2025-01-16T07:12:14+00:00","article_modified_time":"2025-05-26T10:02:52+00:00","og_image":[{"width":1024,"height":767,"url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/WhiteHousePR.webp","type":"image\/webp"}],"author":"Sinan Gul","twitter_card":"summary_large_image","twitter_creator":"@MassiveBio","twitter_site":"@MassiveBio","twitter_misc":{"Written by":"Sinan Gul","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/massivebio.com\/massive-bio-recognized-by-white-house-cancer-moonshot\/#article","isPartOf":{"@id":"https:\/\/massivebio.com\/massive-bio-recognized-by-white-house-cancer-moonshot\/"},"author":{"name":"Sinan Gul","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6"},"headline":"Massive Bio Recognized by White House Cancer Moonshot, Launches $15 Million Initiative","datePublished":"2025-01-16T07:12:14+00:00","dateModified":"2025-05-26T10:02:52+00:00","mainEntityOfPage":{"@id":"https:\/\/massivebio.com\/massive-bio-recognized-by-white-house-cancer-moonshot\/"},"wordCount":689,"publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"image":{"@id":"https:\/\/massivebio.com\/massive-bio-recognized-by-white-house-cancer-moonshot\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/WhiteHousePR.webp","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/massivebio.com\/massive-bio-recognized-by-white-house-cancer-moonshot\/","url":"https:\/\/massivebio.com\/massive-bio-recognized-by-white-house-cancer-moonshot\/","name":"Massive Bio today proudly announces its inclusion in the White House Office of Science & Technology Policy\u2019s upcoming Cancer Moonshot Fact Sheet.","isPartOf":{"@id":"https:\/\/massivebio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/massivebio.com\/massive-bio-recognized-by-white-house-cancer-moonshot\/#primaryimage"},"image":{"@id":"https:\/\/massivebio.com\/massive-bio-recognized-by-white-house-cancer-moonshot\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/WhiteHousePR.webp","datePublished":"2025-01-16T07:12:14+00:00","dateModified":"2025-05-26T10:02:52+00:00","description":"Massive Bio Recognized by White House Cancer Moonshot for First-of-Their-Kind Pre-Screening Hubs and AI-Powered Trial Matching, Launches $15 Million Initiative at JPM 2025.","breadcrumb":{"@id":"https:\/\/massivebio.com\/massive-bio-recognized-by-white-house-cancer-moonshot\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/massivebio.com\/massive-bio-recognized-by-white-house-cancer-moonshot\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/massive-bio-recognized-by-white-house-cancer-moonshot\/#primaryimage","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/WhiteHousePR.webp","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/WhiteHousePR.webp","width":1024,"height":767,"caption":"WhiteHousePR"},{"@type":"BreadcrumbList","@id":"https:\/\/massivebio.com\/massive-bio-recognized-by-white-house-cancer-moonshot\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Homepage","item":"https:\/\/massivebio.com\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/massivebio.com\/resources\/news-en\/"},{"@type":"ListItem","position":3,"name":"Massive Bio Recognized by White House Cancer Moonshot, Launches $15 Million Initiative"}]},{"@type":"WebSite","@id":"https:\/\/massivebio.com\/#website","url":"https:\/\/massivebio.com\/","name":"Cancer Analysis and Clinical Trial Matching","description":"Best Oncology Advisory Services By Cancer Treatment Care Specialists &amp; Tumor Board Experts in America","publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/massivebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/massivebio.com\/#organization","name":"Massive Bio","url":"https:\/\/massivebio.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","width":"1024","height":"1024","caption":"Massive Bio"},"image":{"@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","https:\/\/x.com\/MassiveBio","https:\/\/instagram.com\/massive_bio\/","https:\/\/tiktok.com\/@massivebio","https:\/\/youtube.com\/massivebio"],"email":"support@massivebio.com","legalName":"Massive Bio"},{"@type":"Person","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6","name":"Sinan Gul"}]}},"_links":{"self":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/31765","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/comments?post=31765"}],"version-history":[{"count":13,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/31765\/revisions"}],"predecessor-version":[{"id":35539,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/31765\/revisions\/35539"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media\/31766"}],"wp:attachment":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media?parent=31765"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/categories?post=31765"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/tags?post=31765"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}